Catalent, Inc. (CTLT) Financials
Stock symbol CTLT is outdated, potentially delisted? Maybe it is available on other exchange?
CTLT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 9.7 billion | 6.2 billion |
| June 30, 2024 | 9.8 billion | 6.1 billion |
| March 31, 2024 | 9.9 billion | 6.3 billion |
| Dec. 31, 2023 | 10.0 billion | 6.3 billion |
CTLT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | 4.0 million | 17.0 million |
| June 30, 2024 | 139.0 million | 16.0 million |
| March 31, 2024 | -62.0 million | 17.0 million |
| Dec. 31, 2023 | 18.0 million | 16.0 million |
CTLT Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2024 | -129.0 million |
| June 30, 2024 | 23.0 million |
| March 31, 2024 | -101.0 million |
| Dec. 31, 2023 | -206.0 million |
CTLT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 335.0 million | 4.9 billion | 13.0 million |
| June 30, 2024 | 289.0 million | 4.9 billion | 395.0 million |
| March 31, 2024 | 162.0 million | 4.9 billion | 10.0 million |
| Dec. 31, 2023 | 229.0 million | 5.0 billion | 9.0 million |
CTLT Shares Outstanding
CTLT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 57.0 million | 5.0 million | 252.0 million | - |
| June 30, 2024 | 75.0 million | 5.0 million | 218.0 million | - |
| March 31, 2024 | 74.0 million | 4.0 million | 214.0 million | - |
| Dec. 31, 2023 | 94.0 million | 4.0 million | 180.0 million | - |
CTLT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 1.0 billion | 842.0 million |
| June 30, 2024 | 1.3 billion | 917.0 million |
| March 31, 2024 | 1.1 billion | 845.0 million |
| Dec. 31, 2023 | 1.0 billion | 853.0 million |
CTLT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CTLT
Price: $63.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.28 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 3.0 million
Ebitda: 115.6 millionMarket Capitalization: 11.3 billion